Published in Dis Manag on April 01, 2006
A nurse-coordinated model of care versus usual care for stage 3/4 chronic kidney disease in the community: a randomized controlled trial. Clin J Am Soc Nephrol (2011) 1.58
Angiotensin-(1-7) and the g protein-coupled receptor MAS are key players in renal inflammation. PLoS One (2009) 1.12
High burden and unmet patient needs in chronic kidney disease. Int J Nephrol Renovasc Dis (2012) 1.00
Higher serum direct bilirubin levels were associated with a lower risk of incident chronic kidney disease in middle aged Korean men. PLoS One (2014) 0.81
Venous thromboembolism in patients with reduced estimated GFR: a population-based perspective. Am J Kidney Dis (2011) 0.81
The prevalence of chronic kidney disease in a primary care setting: a Swiss cross-sectional study. PLoS One (2013) 0.80
Prevalence of renal impairment among osteoporotic women in the USA, NHANES 2005-2008: is treatment with bisphosphonates an option? Osteoporos Int (2014) 0.76
Effects of amino acids and albumin on erythropoietin carbamoylation. Clin Exp Nephrol (2012) 0.75
Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med (2004) 7.79
Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. JAMA (2012) 6.26
Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts. Kidney Int (2011) 5.25
Prescription drug use in pregnancy. Am J Obstet Gynecol (2004) 4.92
Geographic variation in cardiovascular procedure use among Medicare fee-for-service vs Medicare Advantage beneficiaries. JAMA (2013) 3.30
ADHD medications and risk of serious cardiovascular events in young and middle-aged adults. JAMA (2011) 2.77
The ankle-brachial index for peripheral artery disease screening and cardiovascular disease prediction among asymptomatic adults: a systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med (2013) 2.62
Use of antidepressant medications during pregnancy: a multisite study. Am J Obstet Gynecol (2007) 2.61
Effect of increased cost-sharing on oral hypoglycemic use in five managed care organizations: how much is too much? Med Care (2005) 2.33
Electronic medical record reminder improves osteoporosis management after a fracture: a randomized, controlled trial. J Am Geriatr Soc (2006) 2.33
Low frequency of treatment of osteoporosis among postmenopausal women following a fracture. Arch Intern Med (2003) 2.19
How to design computerized alerts to safe prescribing practices. Jt Comm J Qual Saf (2004) 2.11
Potential application of the National Kidney Foundation's chronic kidney disease guidelines in a managed care setting. Am J Manag Care (2004) 2.05
The Cardiovascular Research Network: a new paradigm for cardiovascular quality and outcomes research. Circ Cardiovasc Qual Outcomes (2008) 2.03
Estimating utility data from clinical indicators for patients with stable angina. Eur J Health Econ (2005) 1.78
Surgical outcomes of total knee replacement according to diabetes status and glycemic control, 2001 to 2009. J Bone Joint Surg Am (2013) 1.76
Use of prescription medications with a potential for fetal harm among pregnant women. Pharmacoepidemiol Drug Saf (2006) 1.73
Reducing warfarin medication interactions: an interrupted time series evaluation. Arch Intern Med (2006) 1.67
AHRQ series paper 4: assessing harms when comparing medical interventions: AHRQ and the effective health-care program. J Clin Epidemiol (2008) 1.57
Trends in elective labor induction for six United States health plans, 2001-2007. J Womens Health (Larchmt) (2014) 1.54
Predicting the risk of dialysis and transplant among patients with CKD: a retrospective cohort study. Am J Kidney Dis (2008) 1.54
Automated telephone calls improved completion of fecal occult blood testing. Med Care (2010) 1.50
Effects of graded-release diltiazem versus ramipril, dosed at bedtime, on early morning blood pressure, heart rate, and the rate-pressure product. Am Heart J (2004) 1.44
Computerized prescribing alerts and group academic detailing to reduce the use of potentially inappropriate medications in older people. J Am Geriatr Soc (2006) 1.40
Older women with fractures: patients falling through the cracks of guideline-recommended osteoporosis screening and treatment. J Bone Joint Surg Am (2003) 1.40
Antidepressant medication use and risk of persistent pulmonary hypertension of the newborn. Pharmacoepidemiol Drug Saf (2009) 1.38
Improved therapeutic monitoring with several interventions: a randomized trial. Arch Intern Med (2006) 1.37
The near absence of osteoporosis treatment in older men with fractures. Osteoporos Int (2005) 1.35
Weight change in diabetes and glycemic and blood pressure control. Diabetes Care (2008) 1.34
Predicting renal replacement therapy and mortality in CKD. Am J Kidney Dis (2007) 1.34
Quantifying losses to the donated blood supply due to donor deferral and miscollection. Transfusion (2004) 1.29
Systolic blood pressure and mortality among older community-dwelling adults with CKD. Am J Kidney Dis (2010) 1.24
Outpatient use of cardiovascular drugs during pregnancy. Pharmacoepidemiol Drug Saf (2008) 1.21
Validity of health plan and birth certificate data for pregnancy research. Pharmacoepidemiol Drug Saf (2012) 1.20
Opioids for back pain patients: primary care prescribing patterns and use of services. J Am Board Fam Med (2011) 1.14
Atrial fibrillation and outcomes in heart failure with preserved versus reduced left ventricular ejection fraction. J Am Heart Assoc (2013) 1.12
Effect of a patient panel-support tool on care delivery. Am J Manag Care (2010) 1.08
Medication Exposure in Pregnancy Risk Evaluation Program. Matern Child Health J (2012) 1.08
Change to FIT increased CRC screening rates: evaluation of a US screening outreach program. Am J Manag Care (2012) 1.05
Cluster randomized trials to study the comparative effectiveness of therapeutics: stakeholders' concerns and recommendations. Pharmacoepidemiol Drug Saf (2009) 1.03
Prevalence and trends in the use of antipsychotic medications during pregnancy in the U.S., 2001-2007: a population-based study of 585,615 deliveries. Arch Womens Ment Health (2013) 1.03
Use of health information technology to improve medication adherence. Am J Manag Care (2011) 1.03
Effect of ergocalciferol supplementation on serum parathyroid hormone and serum 25-hydroxyvitamin D in chronic kidney disease. Nephrology (Carlton) (2006) 1.01
Impact of comorbidities on mortality in managed care patients with CKD. Am J Kidney Dis (2006) 1.01
Correlates of higher-dose opioid medication use for low back pain in primary care. J Pain (2012) 0.99
Potential drug-drug interactions in the outpatient setting. Med Care (2006) 0.96
Community blood supply model: development of a new model to assess the safety, sufficiency, and cost of the blood supply. Med Decis Making (2005) 0.94
Contemporary prevalence and correlates of incident heart failure with preserved ejection fraction. Am J Med (2013) 0.93
Patterns of comorbidity in older adults with heart failure: the Cardiovascular Research Network PRESERVE study. J Am Geriatr Soc (2013) 0.93
Effect of anaemia on mortality, cardiovascular hospitalizations and end-stage renal disease among patients with chronic kidney disease. Nephrology (Carlton) (2009) 0.93
Diabetes and drug-associated hyperkalemia: effect of potassium monitoring. J Gen Intern Med (2010) 0.93
Hyperparathyroidism in chronic kidney disease: a retrospective cohort study of costs and outcomes. J Bone Miner Metab (2009) 0.93
Nurse-coordinated care in CKD: time for translation into practice? Clin J Am Soc Nephrol (2011) 0.91
Cluster randomized trials: opportunities and barriers identified by leaders of eight health plans. Med Care (2007) 0.91
Epidemiology and healthcare costs of incident Clostridium difficile infections identified in the outpatient healthcare setting. Infect Control Hosp Epidemiol (2012) 0.91
Validation of an algorithm to estimate gestational age in electronic health plan databases. Pharmacoepidemiol Drug Saf (2013) 0.90
Sex- and age-specific trends in antibiotic resistance patterns of Escherichia coli urinary isolates from outpatients. BMC Fam Pract (2013) 0.90
Longitudinal study of implantable cardioverter-defibrillators: methods and clinical characteristics of patients receiving implantable cardioverter-defibrillators for primary prevention in contemporary practice. Circ Cardiovasc Qual Outcomes (2012) 0.89
Weight change and glycemic control after diagnosis of type 2 diabetes. J Gen Intern Med (2008) 0.89
Predicting costs of care in heart failure patients. BMC Health Serv Res (2012) 0.88
Dabigatran bleed risk with closed head injuries: are we prepared? J Neurosurg (2013) 0.88
Prevalence, trends, and patterns of use of antidiabetic medications among pregnant women, 2001-2007. Obstet Gynecol (2013) 0.87
Lower visual acuity predicts worse utility values among patients with type 2 diabetes. Qual Life Res (2008) 0.87
A primary care-based interdisciplinary team approach to the treatment of chronic pain utilizing a pragmatic clinical trials framework. Transl Behav Med (2012) 0.86
Predicting the risk of end-stage renal disease in the population-based setting: a retrospective case-control study. BMC Nephrol (2011) 0.86
Reducing the prescribing of heavily marketed medications: a randomized controlled trial. J Gen Intern Med (2009) 0.86
Predicting the risk of hyperkalemia in patients with chronic kidney disease starting lisinopril. Pharmacoepidemiol Drug Saf (2010) 0.85
Methods of linking mothers and infants using health plan data for studies of pregnancy outcomes. Pharmacoepidemiol Drug Saf (2013) 0.85
Risk factors for adverse outcomes by left ventricular ejection fraction in a contemporary heart failure population. Circ Heart Fail (2013) 0.85
Primary care colorectal cancer screening recommendation patterns: associated factors and screening outcomes. Med Decis Making (2011) 0.85
Sickle cell trait protects against Plasmodium falciparum infection. Am J Epidemiol (2012) 0.85
Surface deposition and phase behavior of oppositely charged polyion/surfactant ion complexes. 1. Cationic guar versus cationic hydroxyethylcellulose in mixtures with anionic surfactants. ACS Appl Mater Interfaces (2009) 0.85
Proteinuria among patients with chronic kidney disease: a performance measure for improving patient outcomes. Jt Comm J Qual Patient Saf (2012) 0.84
An outreach program improved osteoporosis management after a fracture. J Am Geriatr Soc (2007) 0.84
Increasingly restrictive definitions of hyperkalemia outcomes in a database study: effect on incidence estimates. Pharmacoepidemiol Drug Saf (2010) 0.84
Health care worker perspectives inform optimization of patient panel-support tools: a qualitative study. Popul Health Manag (2012) 0.83
Rationale, design, and methods for the risk evaluation and communication health outcomes and utilization trial (REACH OUT). Contemp Clin Trials (2007) 0.83
Prescription opioids for back pain and use of medications for erectile dysfunction. Spine (Phila Pa 1976) (2013) 0.83
Predicting poor outcomes in heart failure. Perm J (2011) 0.83
Measuring patient persistency with drug therapy using methods for the design and analysis of natural history studies. Am J Manag Care (2002) 0.82
Comparison of medication practices in patients with heart failure and preserved versus those with reduced ejection fraction (from the Cardiovascular Research Network [CVRN]). Am J Cardiol (2013) 0.81
More comprehensive discussion of CRC screening associated with higher screening. Am J Manag Care (2013) 0.80
Surface adsorption and phase separation of oppositely charged polyion-surfactant ion complexes: 3. Effects of polyion hydrophobicity. Langmuir (2010) 0.80
Clinician's use of automated reports of estimated glomerular filtration rate: a qualitative study. BMC Nephrol (2012) 0.80
Comparison of antibiograms developed for inpatients and primary care outpatients. Diagn Microbiol Infect Dis (2013) 0.79
Clostridium difficile infection, Colorado and the northwestern United States, 2007. Emerg Infect Dis (2012) 0.79
Guideline concordance of testing for hyperkalemia and kidney dysfunction during initiation of mineralocorticoid receptor antagonist therapy in patients with heart failure. Circ Heart Fail (2013) 0.79
Improving adherence to cardiovascular disease medications with information technology. Am J Manag Care (2014) 0.78
The prevalence and trends of antiviral medication use during pregnancy in the US: a population-based study of 664,297 deliveries in 2001-2007. Matern Child Health J (2014) 0.78
Inter-observer agreement according to malaria parasite density. Malar J (2013) 0.78
Crystal structure of a new benzoic acid inhibitor of influenza neuraminidase bound with a new tilt induced by overpacking subsite C6. BMC Struct Biol (2012) 0.77